Literature DB >> 32282938

Molecular subtype, biological sex and age shape melanoma tumour evolution.

M Lotz1, T Budden2, S J Furney3,4, A Virós2.   

Abstract

BACKGROUND: Many cancer types display sex and age disparity in incidence and outcome. The mutational load of tumours, including melanoma, varies according to sex and age. However, there are no tools to explore systematically whether clinical variables such as age and sex determine the genomic landscape of cancer.
OBJECTIVES: To establish a mathematical approach using melanoma mutational data to analyse how sex and age shape the tumour genome.
METHODS: We model how age-related (clock-like) somatic mutations that arise during cell division, and extrinsic (environmental ultraviolet radiation) mutations accumulate in cancer genomes.
RESULTS: Melanoma is driven primarily by cell-intrinsic age-related mutations and extrinsic ultraviolet radiation-induced mutations, and we show that these mutation types differ in magnitude and chronology and by sex in the distinct molecular melanoma subtypes. Our model confirms that age and sex are determinants of cellular mutation rate, shaping the final mutation composition. We show mathematically for the first time how, similarly to noncancer tissues, melanoma genomes reflect a decline in cell division during ageing. We find that clock-like mutations strongly correlate with the acquisition of ultraviolet-induced mutations, but critically, men present a higher number and rate of cell-division-linked mutations.
CONCLUSIONS: These data indicate that the contribution of environmental damage to melanoma likely extends beyond genetic damage to affect cell division. Sex and age determine the final mutational composition of melanoma.
© 2020 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.

Entities:  

Mesh:

Year:  2020        PMID: 32282938      PMCID: PMC7613609          DOI: 10.1111/bjd.19128

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   11.113


  34 in total

Review 1.  Stem cells and healthy aging.

Authors:  Margaret A Goodell; Thomas A Rando
Journal:  Science       Date:  2015-12-04       Impact factor: 47.728

Review 2.  Melanoma.

Authors:  Dirk Schadendorf; Alexander C J van Akkooi; Carola Berking; Klaus G Griewank; Ralf Gutzmer; Axel Hauschild; Andreas Stang; Alexander Roesch; Selma Ugurel
Journal:  Lancet       Date:  2018-09-15       Impact factor: 79.321

3.  Sex Differences in Cancer Driver Genes and Biomarkers.

Authors:  Constance H Li; Syed Haider; Yu-Jia Shiah; Kevin Thai; Paul C Boutros
Journal:  Cancer Res       Date:  2018-10-01       Impact factor: 12.701

4.  Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma.

Authors:  David C Whiteman; Peter Watt; David M Purdie; Maria Celia Hughes; Nicholas K Hayward; Adèle C Green
Journal:  J Natl Cancer Inst       Date:  2003-06-04       Impact factor: 13.506

5.  Sex differences in oncogenic mutational processes.

Authors:  Constance H Li; Stephenie D Prokopec; Ren X Sun; Fouad Yousif; Nathaniel Schmitz; Paul C Boutros
Journal:  Nat Commun       Date:  2020-08-28       Impact factor: 14.919

6.  Ultraviolet radiation-induced DNA damage is prognostic for outcome in melanoma.

Authors:  Lucas D Trucco; Piyushkumar A Mundra; Kate Hogan; Pablo Garcia-Martinez; Amaya Viros; Amit K Mandal; Nicolas Macagno; Caroline Gaudy-Marqueste; Donald Allan; Franziska Baenke; Martin Cook; Clare McManus; Berta Sanchez-Laorden; Nathalie Dhomen; Richard Marais
Journal:  Nat Med       Date:  2018-12-03       Impact factor: 53.440

7.  Clock-like mutational processes in human somatic cells.

Authors:  Ludmil B Alexandrov; Philip H Jones; David C Wedge; Julian E Sale; Peter J Campbell; Serena Nik-Zainal; Michael R Stratton
Journal:  Nat Genet       Date:  2015-11-09       Impact factor: 38.330

8.  Tissue-specific mutation accumulation in human adult stem cells during life.

Authors:  Francis Blokzijl; Joep de Ligt; Myrthe Jager; Valentina Sasselli; Sophie Roerink; Nobuo Sasaki; Meritxell Huch; Sander Boymans; Ewart Kuijk; Pjotr Prins; Isaac J Nijman; Inigo Martincorena; Michal Mokry; Caroline L Wiegerinck; Sabine Middendorp; Toshiro Sato; Gerald Schwank; Edward E S Nieuwenhuis; Monique M A Verstegen; Luc J W van der Laan; Jeroen de Jonge; Jan N M IJzermans; Robert G Vries; Marc van de Wetering; Michael R Stratton; Hans Clevers; Edwin Cuppen; Ruben van Boxtel
Journal:  Nature       Date:  2016-10-03       Impact factor: 49.962

9.  Improving melanoma classification by integrating genetic and morphologic features.

Authors:  Amaya Viros; Jane Fridlyand; Juergen Bauer; Konstantin Lasithiotakis; Claus Garbe; Daniel Pinkel; Boris C Bastian
Journal:  PLoS Med       Date:  2008-06-03       Impact factor: 11.069

10.  Substantial contribution of extrinsic risk factors to cancer development.

Authors:  Song Wu; Scott Powers; Wei Zhu; Yusuf A Hannun
Journal:  Nature       Date:  2015-12-16       Impact factor: 49.962

View more
  3 in total

Review 1.  Advances in sex disparities for cancer immunotherapy: unveiling the dilemma of Yin and Yang.

Authors:  Junfu Ma; Yanxin Yao; Ye Tian; Kexin Chen; Ben Liu
Journal:  Biol Sex Differ       Date:  2022-10-22       Impact factor: 8.811

Review 2.  Melanoma models for the next generation of therapies.

Authors:  E Elizabeth Patton; Kristen L Mueller; David J Adams; Niroshana Anandasabapathy; Andrew E Aplin; Corine Bertolotto; Marcus Bosenberg; Craig J Ceol; Christin E Burd; Ping Chi; Meenhard Herlyn; Sheri L Holmen; Florian A Karreth; Charles K Kaufman; Shaheen Khan; Sebastian Kobold; Eleonora Leucci; Carmit Levy; David B Lombard; Amanda W Lund; Kerrie L Marie; Jean-Christophe Marine; Richard Marais; Martin McMahon; Carla Daniela Robles-Espinoza; Ze'ev A Ronai; Yardena Samuels; Maria S Soengas; Jessie Villanueva; Ashani T Weeraratna; Richard M White; Iwei Yeh; Jiyue Zhu; Leonard I Zon; Marc S Hurlbert; Glenn Merlino
Journal:  Cancer Cell       Date:  2021-02-04       Impact factor: 31.743

3.  Female Immunity Protects from Cutaneous Squamous Cell Carcinoma.

Authors:  Timothy Budden; Caroline Gaudy-Marqueste; Sarah Craig; Yuan Hu; Charles H Earnshaw; Shilpa Gurung; Amelle Ra; Victoria Akhras; Patrick Shenjere; Ruth Green; Lynne Jamieson; John Lear; Luisa Motta; Carlos Caulín; Deemesh Oudit; Simon J Furney; Amaya Virós
Journal:  Clin Cancer Res       Date:  2021-04-01       Impact factor: 13.801

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.